Clinical multidrug resistance in cancer: A multifactorial problem

被引：180
作者：
Lehnert, M
机构：
[1] Cancer Research Laboratory, Department C of Internal Medicine, Kantonsspital
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 06期
关键词：
D O I：
10.1016/0959-8049(96)00069-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：912 / 920
页数：9
相关论文
共 139 条
[1]  
ABO J, 1993, BLOOD, V82, P2829
[2]  
ALBIN N, 1993, CANCER RES, V53, P3541
[3]  
ARCECI RJ, 1993, BLOOD, V81, P2215
[4]   EXPRESSION OF P-GLYCOPROTEIN IN HIGH-GRADE OSTEOSARCOMAS IN RELATION TO CLINICAL OUTCOME [J].
BALDINI, N ;
SCOTLANDI, K ;
BARBANTIBRODANO, G ;
MANARA, MC ;
MAURICI, D ;
BACCI, G ;
BERTONI, F ;
PICCI, P ;
SOTTILI, S ;
CAMPANACCI, M ;
SERRA, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (21) :1380-1385
[5]  
BARRANCO SC, 1994, CANCER RES, V54, P5351
[6]   PHASE-I TRIAL OF DOXORUBICIN WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG-RESISTANCE [J].
BARTLETT, NL ;
LUM, BL ;
FISHER, GA ;
BROPHY, NA ;
EHSAN, MN ;
HALSEY, J ;
SIKIC, BI .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :835-842
[7]   HIGH MDR1- AND MRP-, BUT LOW TOPOISOMERASE-II ALPHA-GENE EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIAS [J].
BECK, J ;
NIETHAMMER, D ;
GEKELER, V .
CANCER LETTERS, 1994, 86 (01) :135-142
[8]  
BECK WT, 1987, CANCER RES, V47, P5455
[9]  
BECK WT, 1979, CANCER RES, V39, P2070
[10]   EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER [J].
BERG, SL ;
TOLCHER, A ;
OSHAUGHNESSY, JA ;
DENICOFF, AM ;
NOONE, M ;
OGNIBENE, FP ;
COWAN, KH ;
BALIS, FM .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2039-2042
12345678910